Cardioxyl Pharmaceuticals
19 articles about Cardioxyl Pharmaceuticals
-
Strong in Immune-Oncology, Bristol-Myers Squibb Branches into Cardiac Meds, Buys Cardioxyl for $2 Billion
11/3/2015
-
Cardioxyl Pharmaceuticals HNO Prodrugs Show Effectiveness In Preclinical Models Following Oral Administration, Improve Hemodynamics In Chronic Diastolic Dysfunction
11/20/2014
-
Cardioxyl Pharmaceuticals Presents Oral Heart Failure Treatment Data For Its Experimental HNO Prodrug At HFSA 18th Annual Scientific Meeting
9/16/2014
-
Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427
7/28/2014
-
New Findings Published in Circulation: Heart Failure Show Potential Utility of Cardioxyl Pharmaceuticals's HNO Donors as Novel Treatments for Heart Failure
10/28/2013
-
Cardioxyl Pharmaceuticals Appoints Shi Yin Foo, M.D., Ph.D., as Chief Medical Officer
9/11/2013
-
Cardioxyl Pharmaceuticals Raises $28 Million in Venture Funding
11/8/2012
-
Cardioxyl Pharmaceuticals Presents Data on its Clinical Candidate, Cxl-1020, at the 60th Annual American College of Cardiology Scientific Session
4/4/2011
-
Cardioxyl Pharmaceuticals Presents Data On Its Clinical Candidate, CXL-1020, at the 60th Annual American College of Cardiology Scientific Session
4/4/2011
-
Cardioxyl Pharmaceuticals Strengthens Executive Team by Appointing James Gilbert, M.D., as Chief Medical Officer
1/11/2011
-
Cardioxyl Pharmaceuticals Initiates Dose-Defining Phase IIa Study of Its Lead Candidate, CXL-1020, in Heart Failure Patients
8/26/2010
-
Cardioxyl Pharmaceuticals Announces Positive Results from First Clinical Study of its Lead Therapy, CXL-1020, in Heart Failure Patients; Cardioxyl Also Secures an Additional $15 Million in Funding
8/2/2010
-
Cardioxyl Pharmaceuticals' Data Presented at American College of Cardiology Annual Scientific Sessions
4/1/2010
-
Cardioxyl Pharmaceuticals Announces Pre-Clinical Results on Lead Clinical Candidate, CXL-1020 at American Heart Association Scientific Sessions 2009
11/18/2009
-
Cardioxyl Pharmaceuticals Announces Late Breaker at American Heart Association Conference
10/29/2009
-
Evotec AG Achieves Milestone With Cardioxyl Pharmaceuticals - as Compound Enters the Clinic
10/1/2009
-
Cardioxyl Pharmaceuticals Presents New Data at the 13th Annual Scientific Meeting of the Heart Failure Society of America
9/15/2009
-
Cardioxyl Pharmaceuticals Initiates Phase I/IIa Study in Heart Failure
7/1/2009
-
Cardioxyl Pharmaceuticals Closes $14.5M Series A Financing
12/6/2006